Seeing Is Believing
Currently out of the existing stock ratings of Sachin Jain, 1 are a HOLD (4.76%), 20 are a BUY (95.24%).
Analyst Sachin Jain, currently employed at BAML, carries an average stock price target met ratio of 76.19% that have a potential upside of 40.32% achieved within 657 days. Previously, Sachin Jain worked at DEUTSCHE BANK.
Sachin Jain’s has documented 31 price targets and ratings displayed on 2 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on AZN, AstraZeneca PLC ADR at 25-Nov-2025.
Analyst best performing recommendations are on NVO (NOVO NORDISK A/S).
The best stock recommendation documented was for AZN (ASTRAZENECA PLC ADR) at 1/26/2018. The price target of $84.7 was fulfilled within 692 days with a profit of $26.59 (45.76%) receiving and performance score of 0.66.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 02-Dec-2019
$240
$68.51 (39.95%)
$105
6 months 26 days ago
(30-Mar-2026)
12/15 (80%)
$47.4 (24.61%)
572
Buy Since 27-Jan-2020
$220
$48.51 (28.29%)
$174
6 months 29 days ago
(27-Mar-2026)
5/16 (31.25%)
$32.82 (17.53%)
570
Buy Since 11-Apr-2023
$109
$-62.49 (-36.44%)
$168
7 months 24 days ago
(02-Mar-2026)
1/3 (33.33%)
$-93.39 (-46.14%)
128
Buy Since 05-Sep-2023
$108.5
$-79.91 (-42.41%)
$91.7
11 months 1 days ago
(25-Nov-2025)
1/6 (16.67%)
$-76.04 (-41.21%)
483
Hold Since 27-Oct-2025
11 months 29 days ago
(27-Oct-2025)
2/3 (66.67%)
$-6.12 (-4.81%)
958
What Year was the first public recommendation made by Sachin Jain?